admin

Chad Robins, CEO of Adaptive Biotechnologies. Anjali Sundaram | CNBC Check out the companies making headlines after the bell. Adaptive Biotechnologies – The biotechnology company’s stock fell 5% in extended trading after Adaptive gave its first-quarter financial results. The company reported a loss of 25 cents per share on revenue of $20.9 million, while analysts
0 Comments
Return on Capital Employed (ROCE) vs. Return on Assets (ROA): An Overview Key Takeaways Return on capital employed (ROCE) and return on assets (ROA) are profitability ratios. ROCE is similar to return on equity (ROE), except it includes debt liabilities, where a higher ratio means a company is making good use of its available capital.
0 Comments
Square (NYSE:SQ) looked like it was prepped for a bearish response to earnings. SQ stock originally fell 6% to 8% in after-hours trading when it released its first-quarter earnings. Source: Piotr Swat / Shutterstock.com However, shares turned around once investors digested the quarter and listened to the conference call. SQ stock climbed almost 10% in
0 Comments
In the week ending May 8, Chesapeake Energy (NYSE:CHK) shares rose nearly 3%. The beleaguered energy company moved in tandem with other oil stocks as the price of oil moved higher. However, in the last month alone, CHK stock has dropped over 50% amid reports that a bankruptcy is imminent. Source: Novikov Aleksey / Shutterstock.com
0 Comments
Lloyd Blankfein, the ex-Goldman Sachs CEO whose bank accepted bailout funds during the financial crisis, said that large companies should be “very reluctant” to take taxpayer money amid the coronavirus pandemic.  “Big companies should be very reluctant to take government money,” Blankfein said Thursday on CNBC’s Squawk Box in response to a question about how
0 Comments
A worker examines cannabis plants at a Tilray farm. Source: Tilray Check out the companies making headlines after the bell. Novavax — The vaccine company’s stock skyrocketed 37% in extended trading after Novavax highlighted an outside investment of $388 million to advance the clinical development of its coronavirus vaccine candidate in its first-quarter earnings release. The
0 Comments
It’s a bit unusual for someone at the corporate level of a large-cap company to predict a stock’s low point during a crisis. That’s precisely what’s happening, however, in the case of JetBlue Airways (NASDAQ:JBLU) stock. Source: Roman Tiraspolsky / Shutterstock.com Calling stock-price bottoms is usually best left to qualified financial analysts (and, of course,
0 Comments